Lanean...
Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer
Non-small-cell lung cancer (NSCLC) accounts for 85%–90% of all cases of lung cancer that is the most deadly type of cancer. Despite advances in chemotherapy and radiotherapy, severe side effects and frequent drug resistance limit the success of the treatments, and the identification of new therapeut...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2019-09-01
|
| Saila: | Molecular Therapy: Nucleic Acids |
| Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S2162253119301635 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|